Cargando…
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds
Deregulation of the mevalonate pathway is known to be involved in a number of diseases that exhibit a systemic inflammatory phenotype and often neurological involvements, as seen in patients suffering from a rare disease called mevalonate kinase deficiency (MKD). One of the molecular mechanisms unde...
Autores principales: | Tricarico, Paola Maura, Kleiner, Giulio, Valencic, Erica, Campisciano, Giuseppina, Girardelli, Martina, Crovella, Sergio, Knowles, Alessandra, Marcuzzi, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013665/ https://www.ncbi.nlm.nih.gov/pubmed/24758928 http://dx.doi.org/10.3390/ijms15046843 |
Ejemplares similares
-
Alendronate, a double-edged sword acting in the mevalonate pathway
por: TRICARICO, PAOLA MAURA, et al.
Publicado: (2015) -
Mevalonate kinase deficiency and IBD: shared genetic background
por: Bianco, Anna Monica, et al.
Publicado: (2014) -
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
por: Tricarico, Paola Maura, et al.
Publicado: (2013) -
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study
por: Tricarico, Paola Maura, et al.
Publicado: (2013) -
Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link
por: Tricarico, Paola Maura, et al.
Publicado: (2015)